Healthcare’s Most Urgent AI Opportunity
Healthcare organizations don't have an AI ideas problem. They have an AI value velocity problem. Nowhere is that more visible than in the revenue cycle.
The pressure is real and the numbers are hard to argue with. Median health system operating margins held near 1% throughout 2025. Expenses are rising at roughly 6% annually while revenue grows at only 3%. For CFOs trying to protect cash flow in that environment, the revenue cycle is no longer a back-office function. It's a strategic lever — and the organizations treating it that way are pulling ahead.
The staffing model is broken
For years, the default response to revenue cycle volume was to add people. More denials? Hire more follow-up billers. More complex claims? Expand the team. That model was already strained before recent pressures accelerated the breaking point.
Labor shortages now affect 83% of healthcare leaders across the revenue cycle, and 90% report that those challenges are making operations worse. At the same time, payer audit volumes increased 30% year-over-year in 2025, with the average at-risk amount per audit rising 18%. That is not a workload a hiring plan can absorb.
The structural response from leading health systems is to redesign where human judgment is actually required. The transactional, rules-based, high-volume work that has historically consumed the majority of revenue cycle staff hours is exactly where technology performs best. Eligibility verification, prior authorization, claims scrubbing, remittance posting, denial routing — these are pattern-matching tasks that humans perform consistently but slowly, and that machines can perform at scale with fewer errors.
That frees your people for the work that actually requires them: complex claims, payer escalations, clinical documentation, and the judgment calls that no automation can replace.
The denial problem is where the most money is lost
Claim denial rates hit 11.8% of initial submissions in 2024. And 65% of those denied claims are never reworked.
That number should stop every CFO in their tracks. Two-thirds of denied claims just disappear. The revenue is earned. The work was done. The patient was seen. And the money never comes back because nobody had the bandwidth or the prioritization system to chase it.
The more important question is upstream: why are those claims being denied in the first place? Machine learning models that flag at-risk claims before they're submitted address the problem at the source. Preventing a denial costs a fraction of what it takes to appeal one after the fact — and most appeals never happen anyway.
This is where the difference between adding AI tools and building an AI-native operating model becomes clear. A tool flags denials after they happen. An operating model redesigns the workflow so fewer claims fail to begin with.
The right framework isn't cost-to-collect
Most revenue cycle performance measurement still centers on cost-to-collect: how efficiently are we processing claims? It's a necessary question, but an incomplete one.
The question it leaves out is consequential: how much revenue are we failing to capture?
When two-thirds of denied claims go unworked and underpayments from commercial payers drain 1-3% of net revenue annually, the financial impact of missed revenue often exceeds whatever savings come from incremental cost reductions. An organization can optimize cost-to-collect and still significantly underperform financially if revenue leakage isn't addressed.
A more complete view requires both sides of the equation: cost efficiency and revenue capture. ROI becomes the unifying metric — it quantifies what prevention and recovery programs actually return and gives CFOs a clear basis for evaluating technology investments as a margin protection strategy, not just an operational one.
What an AI-native revenue cycle actually looks like
The organizations building this well share some common traits.
Internal teams are focused on high-complexity, judgment-intensive work. Automation handles the predictable, transactional volume. And the technology layer isn't a collection of point solutions bolted on to an existing process — it's designed to work across the cycle, with consistent data, consistent governance, and a clear view of where value is being created.
That last part is harder than it sounds. 86% of health systems report using AI in some capacity. But using AI and deploying it in a way that produces measurable, governed outcomes are very different things. The gap between those two states is where most organizations are stuck.
The bottleneck isn't ideas. It's the operating model.
Getting from AI pilot to governed production impact in the revenue cycle requires three things working together: a clear-eyed strategy that identifies where AI creates the most measurable value, the technical and delivery capability to build and deploy it without a two-year implementation timeline, and an enablement layer that makes adoption repeatable across the teams doing the work every day.
Where Productive Edge fits
Productive Edge is a healthcare AI acceleration company. That's not a marketing phrase — it describes a specific way of working. We help health systems move from AI opportunity to governed production impact faster, through three interconnected capabilities.
Actionable Strategy defines the right AI opportunities in the revenue cycle — where value is highest, what the ROI logic looks like, and what the delivery path needs to be. Not a consulting artifact that sits on a shelf, but a Factory Brief that feeds directly into execution.
Forward-Deployed Factory Pods are smaller, AI-native teams embedded with your people to move from roadmap to production. A Scout shapes business intent and builds the brief. Builders take it through the Software Factory. AI agents handle the labor in between. Humans hold the gates.
AI Enablement Accelerators — including Boost Health AI and our Operating Model Playbooks — make adoption repeatable. Not a one-time deployment, but a system that compounds over time as learnings feed back into the next cycle.
The revenue cycle is one of the highest-ROI opportunities in healthcare AI right now. The pressure is real, the use cases are well-defined, and the organizations moving decisively are creating durable financial advantages.
If your team is working through where to start — or trying to move faster than your current approach allows — we'd welcome the conversation.
Schedule a demo with Productive Edge →
Sources
- Strata Decision Technology (2025): Median health system operating margins held near 1% throughout 2025. https://www.stratadecision.com/press-release/margins-remain-narrow-us-hospitals-face-intensifying-expense-pressures-and-growing
- Plante Moran / ACHE Healthcare Executive (2025): Expenses rising ~6% annually vs. ~3% revenue growth. https://www.healthcareexecutive.org/sponsored-content/navigating-financial-pressures-in-2025
- ACHE (2023): Labor shortages affect 83% of healthcare leaders across the revenue cycle. https://www.ache.org/blog/2023/power-your-revenue-cycle-with-automation-and-ai
- Notable Health (2025): 90% of healthcare leaders say revenue cycle labor challenges worsen operations; 86% already using AI in some capacity. https://www.notablehealth.com/blog/ai-and-automation-in-revenue-cycle-management-must-know-trends-for-2025
- Fierce Healthcare (2025): Payer audit volumes up 30% YoY; average at-risk amount per audit up 18%. https://www.fiercehealthcare.com/finance/payer-audits-denial-amounts-rise-again-2025-vendor-data-show
- Omega Healthcare (2025): Claim denial rate at 11.8% of initial submissions in 2024. https://www.os-healthcare.com/news-and-blog/denial-rates-are-climbing-what-healthcare-revenue-cycle-leaders-should-be-watching-in-2025
- Aptarro: 65% of denied claims are never reworked. https://www.aptarro.com/insights/us-healthcare-denial-rates-reimbursement-statistics
- Fierce Healthcare / Revecore (2026): Full article context for revenue cycle operating model shift. https://www.fiercehealthcare.com/sponsored/revenue-cycle-model-being-rebuilt-and-cfos-are-leading-way
